![PDF) Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia PDF) Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia](https://i1.rgstatic.net/publication/221692757_Inhibition_of_the_LSD1_KDM1A_demethylase_reactivates_the_all-trans-retinoic_acid_differentiation_pathway_in_acute_myeloid_leukemia/links/0912f505bd75fe7d96000000/largepreview.png)
PDF) Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
UNIVERSITÉ PARIS DESCARTES École Doctorale Médicament, Toxicologie, Chimie, Imageries UNIVERSIDADE DO PORTO Faculdade de Farm
Deciphering the role of autophagy- mediated focal adhesion turnover in cancer cells and therapeutic implications
![PDF) MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity PDF) MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity](https://i1.rgstatic.net/publication/42109250_MCF-7_breast_cancer_cells_selected_for_tamoxifen_resistance_acquire_new_phenotypes_differing_in_DNA_content_phospho-HER2_and_PAX2_expression_and_rapamycin_sensitivity/links/55a41eb308ae5e82ab1f30f8/largepreview.png)
PDF) MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity
![Role of circadian rhythm disorders on EMT and tumour–immune interactions in endocrine-related cancers in: Endocrine-Related Cancer Volume 28 Issue 2 (2021) Role of circadian rhythm disorders on EMT and tumour–immune interactions in endocrine-related cancers in: Endocrine-Related Cancer Volume 28 Issue 2 (2021)](https://erc.bioscientifica.com/view/journals/erc/28/2/images/ERC-20-0390fig2.jpeg)
Role of circadian rhythm disorders on EMT and tumour–immune interactions in endocrine-related cancers in: Endocrine-Related Cancer Volume 28 Issue 2 (2021)
![Role of circadian rhythm disorders on EMT and tumour–immune interactions in endocrine-related cancers in: Endocrine-Related Cancer Volume 28 Issue 2 (2021) Role of circadian rhythm disorders on EMT and tumour–immune interactions in endocrine-related cancers in: Endocrine-Related Cancer Volume 28 Issue 2 (2021)](https://erc.bioscientifica.com/view/journals/erc/28/2/images/ERC-20-0390fig1.jpeg)